{"id":"https://openalex.org/W2016228987","doi":"https://doi.org/10.1016/s0009-9236(96)80010-5","title":"Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin*","display_name":"Plasma levels of the enantiomers of thioridazine, thioridazine 2-sulfoxide, thioridazine 2-sulfone, and thioridazine 5-sulfoxide in poor and extensive metabolizers of dextromethorphan and mephenytoin*","publication_year":1996,"publication_date":"1996-03-01","ids":{"openalex":"https://openalex.org/W2016228987","doi":"https://doi.org/10.1016/s0009-9236(96)80010-5","mag":"2016228987","pmid":"https://pubmed.ncbi.nlm.nih.gov/8653995"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(96)80010-5","doi":"https://doi.org/10.1016/s0009-9236(96)80010-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(96)80010-5","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004418235","display_name":"Chin B. Eap","orcid":"https://orcid.org/0000-0002-5439-0230","observed_orcids":["https://orcid.org/0000-0002-5439-0230"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Chin B. Eap","raw_affiliation_strings":["D\u00e9partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","F. Hoffmann-La Roche AG, Basel, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":[]},{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110141452","display_name":"Theodor W. Guentert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210097795","display_name":"H\u00f4pital de Cery","ror":"https://ror.org/00vqmez57","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882","https://openalex.org/I4210097795"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Theo W. Guentert","raw_affiliation_strings":["F. Hoffmann-La Roche AG, Basel, Switzerland","Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":["https://openalex.org/I4210097795"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056022289","display_name":"Martina Sch\u00e4ublin-Loidl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210097795","display_name":"H\u00f4pital de Cery","ror":"https://ror.org/00vqmez57","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882","https://openalex.org/I4210097795"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martina Sch\u00e4ublin-Loidl","raw_affiliation_strings":["F. Hoffmann-La Roche AG, Basel, Switzerland","Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":["https://openalex.org/I4210097795"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011753600","display_name":"Max Stabl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210097795","display_name":"H\u00f4pital de Cery","ror":"https://ror.org/00vqmez57","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882","https://openalex.org/I4210097795"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Max Stabl","raw_affiliation_strings":["F. Hoffmann-La Roche AG, Basel, Switzerland","Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":["https://openalex.org/I4210097795"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040204924","display_name":"Liliane Koeb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210097795","display_name":"H\u00f4pital de Cery","ror":"https://ror.org/00vqmez57","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882","https://openalex.org/I4210097795"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Liliane Koeb","raw_affiliation_strings":["F. Hoffmann-La Roche AG, Basel, Switzerland","Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":["https://openalex.org/I4210097795"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108191804","display_name":"Kerry Powell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210097795","display_name":"H\u00f4pital de Cery","ror":"https://ror.org/00vqmez57","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882","https://openalex.org/I4210097795"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Kerry Powell","raw_affiliation_strings":["F. Hoffmann-La Roche AG, Basel, Switzerland","Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":["https://openalex.org/I4210097795"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090969745","display_name":"Pierre Baumann","orcid":"https://orcid.org/0000-0002-6253-5225","observed_orcids":["https://orcid.org/0000-0002-6253-5225","https://orcid.org/0009-0003-8140-8779"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I4210097795","display_name":"H\u00f4pital de Cery","ror":"https://ror.org/00vqmez57","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882","https://openalex.org/I4210097795"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Pierre Baumann","raw_affiliation_strings":["F. Hoffmann-La Roche AG, Basel, Switzerland","Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Unite\u0301 de Biochimie et Psychopharmacologie Clinique, De\u0301partement Universitaire de Psychiatrie Adulte, Prilly-Lausanne, Switzerland","institution_ids":["https://openalex.org/I4210097795"]},{"raw_affiliation_string":"Unit\u00e9 de Biochimie et Psychopharmacologie Clinique, D\u00e9partement Universitaire de Psychiatrie Adulte Prilly-Lausanne Switzerland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004418235"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.0456,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.84981227,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"59","issue":"3","first_page":"322","last_page":"331"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9259999990463257},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.39899998903274536},{"id":"https://openalex.org/keywords/enantioselectivity","display_name":"enantioselectivity","score":0.7710000276565552},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.734000027179718},{"id":"https://openalex.org/keywords/moclobemide","display_name":"moclobemide","score":0.9210000038146973}],"concepts":[{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.9966732263565063},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43555590510368347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3812195956707001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16619873046875},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.14039123058319092}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000996","descriptor_name":"Antitussive Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003915","descriptor_name":"Dextromethorphan","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008653","descriptor_name":"Mesoridazine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010640","descriptor_name":"Phenothiazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/s0009-9236(96)80010-5","doi":"https://doi.org/10.1016/s0009-9236(96)80010-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(96)80010-5","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:8653995","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8653995","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"},{"id":"pmh:oai:iris.unil.ch:iris/32865","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/32865","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:serval.unil.ch:BIB_227FD9136C7D","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_227FD9136C7D","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology and Therapeutics, vol. 59, no. 3, pp. 322-331","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W139854314","https://openalex.org/W1856558418","https://openalex.org/W1938835292","https://openalex.org/W1966890749","https://openalex.org/W1972267223","https://openalex.org/W1993020095","https://openalex.org/W1993558201","https://openalex.org/W1997107133","https://openalex.org/W1997586764","https://openalex.org/W2004027772","https://openalex.org/W2004090297","https://openalex.org/W2006744192","https://openalex.org/W2016911934","https://openalex.org/W2027977972","https://openalex.org/W2029146276","https://openalex.org/W2032856475","https://openalex.org/W2036548290","https://openalex.org/W2041477433","https://openalex.org/W2050077040","https://openalex.org/W2051903015","https://openalex.org/W2053041537","https://openalex.org/W2054805202","https://openalex.org/W2066829568","https://openalex.org/W2071953688","https://openalex.org/W2082601447","https://openalex.org/W2085203339","https://openalex.org/W2088208249","https://openalex.org/W2090285473","https://openalex.org/W2094989309","https://openalex.org/W2141517785","https://openalex.org/W2146856256","https://openalex.org/W2151711536","https://openalex.org/W2156412357","https://openalex.org/W2417059483"],"related_works":["https://openalex.org/W2039135632","https://openalex.org/W2017272336","https://openalex.org/W2430923224","https://openalex.org/W1030697593","https://openalex.org/W2035990413","https://openalex.org/W2073161666","https://openalex.org/W1544511641","https://openalex.org/W4379519400","https://openalex.org/W7018651117","https://openalex.org/W1977223958"],"abstract_inverted_index":{"Concentrations":[0],"of":[1,7,13,44,52,62,75,84,100,113,137,145,230],"total":[2],"(R)":[3,10],"+":[4],"(S)":[5,12],"and":[6,11,15,31,46,68,98,102,129,164,214,235,240],"the":[8,60,73,82,94,111,135,228],"enantiomers":[9],"thioridazine":[14,27,63,67,76,85,89,101,114,120,122,125,138,147,152,157,160,162,165],"metabolites":[16,103],"were":[17,23,33,41,167],"measured":[18,142],"in":[19,59,72,81,134,227],"21":[20],"patients":[21,40],"who":[22,32],"receiving":[24],"100":[25],"mg":[26],"for":[28],"14":[29],"days":[30],"comedicated":[34],"with":[35],"moclobemide":[36],"(450":[37],"mg/day).":[38],"Two":[39],"poor":[42,50],"metabolizers":[43],"dextromethorphan":[45],"one":[47],"was":[48],"a":[49,130],"metabolizer":[51],"mephenytoin.":[53],"Cytochrome":[54],"P450IID6":[55],"(CYP2D6)":[56],"is":[57,224],"involved":[58,226],"formation":[61,74,83,229],"2-sulfoxide":[64],"(2-SO)":[65],"from":[66,88],"also":[69,236],"probably":[70,237],"partially":[71],"5-sulfoxide":[77],"(5-SO),":[78],"but":[79],"not":[80],"2-sulfone":[86],"(2-SO2)":[87],"2-SO.":[90],"Significant":[91],"correlations":[92],"between":[93],"mephenytoin":[95],"enantiomeric":[96],"ratio":[97],"concentrations":[99],"suggest":[104],"that":[105],"cytochrome":[106],"P450IIC19":[107],"could":[108],"contribute":[109],"to":[110,177,184,191,198,205,212,220],"biotransformation":[112],"into":[115],"yet-unknown":[116],"metabolites,":[117],"other":[118],"than":[119],"2-SO,":[121],"2-SO2,":[123,161],"or":[124],"5-SO.":[126],"An":[127],"enantioselectivity":[128],"large":[131],"interindividual":[132],"variability":[133],"metabolism":[136],"have":[139],"been":[140],"shown:":[141],"(R)/(S)":[143],"ratios":[144],"thioridazine,":[146],"2-SO":[148,153,158],"fast":[149],"eluting":[150,155],"(FE),":[151],"slow":[154],"(SE),":[156],"(FE+SE),":[159],"5-SO(FE),":[163],"5-SO(SE)":[166],"(mean":[168],"+/-":[169,172,180,187,194,201,208,216],"SD)":[170],"3.48":[171],"0":[173],".93":[174],"(range,":[175,182,189,196,203,210,218],"2.30":[176,204],"5.80),":[178],"0.45":[179],"0.22":[181],"0.21":[183],"1.20),":[185],"2.27":[186],"8.1":[188],"6.1":[190],"40.1),":[192],"4.64":[193],"0.68":[195],"2.85":[197],"5.70),":[199],"3.26":[200],"0.58":[202],"4.30),":[206],"0.049":[207],"0.019":[209],"(0.021":[211],"0.087),":[213],"67.2":[215],"66.2":[217],"16.8":[219],"248),":[221],"respectively.":[222],"CYP2D6":[223],"apparently":[225],"(S)-thioridazine":[231,238],"2-SO(FE),":[232],"(R)-thioridazine":[233,241],"2-SO(SE),":[234],"5-SO(FE)":[239],"5-SO(SE).":[242]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}